Location History:
- Houston, TX (US) (2007)
- New City, NY (US) (2010 - 2022)
Company Filing History:
10 out of 31 
1 out of 1 
1 out of 13 
Years Active: 2007-2022
Title: Robert Zhiyong Luo: Pioneering Innovator in Pharmaceutical Technologies
Introduction:
Throughout his remarkable career, Robert Zhiyong Luo has continually pushed the boundaries of innovation, revolutionizing the pharmaceutical industry through groundbreaking technologies. With a strong background in research and development, his inventive ideas have led to the development of novel compounds and therapeutic approaches that hold immense potential in the prevention and treatment of various diseases.
Latest Patents:
Robert's latest patents showcase his expertise in drug development and therapeutic interventions. Two notable inventions include:
1. Substituted pyrrolopyrimidine and pyrazolopyrimidine as Bruton's tyrosine kinase (BTK) degraders: This patented compound series demonstrates the ability to degrade Bruton's tyrosine kinase (BTK), opening new avenues for the prevention and treatment of conditions influenced by this enzyme. These innovative compounds offer promising therapeutic opportunities for patients with BTK-related diseases.
2. Synthetic peptide amides: Robert's inventive work also involves synthetic peptide amides that act as ligands for the kappa opioid receptor. These peptide amides, exhibiting low PCYP inhibition and brain penetration, hold great potential in managing pain and inflammation associated with various diseases. The patent covers a range of therapeutic applications, making it a versatile asset in the pharmaceutical domain.
Career Highlights:
Robert Zhiyong Luo has accumulated an impressive array of achievements and milestones throughout his career. With a keen focus on research and development, his work has led to significant advancements in pharmaceutical technologies. Some of his notable career highlights are:
1. Research Scientist at Cara Therapeutics, Inc.: Robert made substantial contributions to the development of innovative drug candidates at Cara Therapeutics, Inc. His efforts played a critical role in accelerating the company's research pipeline, bringing novel therapies closer to patients in need.
2. Collaborative Innovations: Robert has collaborated with esteemed professionals in the field of pharmaceutical research. Working alongside notable colleagues such as Claudio Daniel Schteingart and Guangcheng Jiang, he has fostered a culture of innovation and shared expertise, producing groundbreaking advancements in the field.
Conclusion:
Robert Zhiyong Luo is a visionary innovator who has left an indelible mark on the pharmaceutical industry. Through his inventive ideas and relentless pursuit of excellence, he has made significant contributions to drug development and therapeutic interventions. With numerous patents and collaborations under his belt, Robert's work continues to shape the landscape of the industry, offering hope for improved treatments and better patient outcomes.